| 14976-5 |
Lecithin/Sphingomyelin |
Ratio |
Amnio fld |
Pt |
Qn |
|
|
ACTIVE |
Lecithin/Sphingomyelin [Ratio] in Amniotic fluid |
|
MIN |
DefinitionDescription |
|
|
ratio |
|
|
|
|
|
|
CHEM |
|
14976-5 |
|
|
|
|
Both |
|
|
|
0 |
Lecithin/Sphingomyelin Amn-Rto |
|
|
|
Y |
|
AF; Amn; Amn fl; Amnio; Amniotic flu; Amniotic fluid; c470; Chemistry; Choline phosphoglyceride; Phosphatidylcholine; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Rto; SPH; UniversalLabOrders |
2.73 |
1.0k |
|
|
|
|
|
|
|
{ratio} |
|
|
|
0 |
| 14977-3 |
Immunoglobulin light chains.free |
Type |
Urine |
Pt |
Nom |
|
|
ACTIVE |
Immunoglobulin light chains.free [Type] in Urine |
|
MIN |
DefinitionDescription |
|
|
|
Kappa;Lambda |
|
|
|
|
|
CHEM |
|
14977-3 |
|
|
|
|
Both |
|
|
|
0 |
BJ Protein Free Ur |
|
|
|
|
|
Bence Jones protein; BJ Protein; BJ Protein Free; BJP; Chain; Chemistry; FLC; FR; Hematology; Heme; Immune globulin; Immuno; Immunoglob; Immunoglobin; Imunoglbon; Imunoglobn; Nominal; Non-protein bound; Point in time; Random; Typ; UA; UR; Urn |
2.26 |
1.0k |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 14978-1 |
cycloSPORINE |
MCnc |
Bld |
Pt |
Qn |
IA |
|
ACTIVE |
cycloSPORINE [Mass/volume] in Blood by Immunoassay |
|
MIN |
DefinitionDescription |
|
|
ug/L |
|
|
|
|
|
|
DRUG/TOX |
|
14978-1 |
|
IA |
|
|
Both |
|
|
|
0 |
cycloSPORINE Bld IA-mCnc |
|
|
|
Y |
|
Blood; Ciclosporin; Ciclosporine; CsA; Cyclosporin a; Cyclosporins; DRUG/TOXICOLOGY; Drugs; EIA; ELFA; ELISA; Enzyme immunoassay; Gengraf; IAA; Level; Mass concentration; MEIA; Neoral; Point in time; QNT; Quan; Quant; Quantitative; Random; Restasis; Sandimmune; SangCya; SUDS; WB; Whole blood |
2.73 |
1.0k |
|
|
|
|
|
|
|
ug/L |
|
|
The EIA method, which was always intended to cover more than just enzyme-linked immunoassay and whose display name for the long common name has always been Immunoassay, was renamed IA in order to eliminate ambiguity about whether the method has a broader meaning than just enzyme-linked immunoassay. Likewise, EIA.rapid was renamed IA.rapid. These changes were approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14979-9 |
Coagulation surface induced |
Time |
PPP |
Pt |
Qn |
Coag |
|
ACTIVE |
aPTT in Platelet poor plasma by Coagulation assay |
|
MIN |
DefinitionDescription |
|
|
s |
|
|
|
|
|
|
COAG |
|
14979-9 |
|
Coag |
|
|
Both |
|
|
|
0 |
aPTT PPP |
|
|
|
Y |
|
Activated partial thromboplastin time; aPTT; Clot; Clottable; Coag; Coagulation assay; Hematology; Heme; Little(A)PTT; Partial Thromboplastin Time; Plas; Platelet poor plasma; Point in time; PTT; QNT; Quan; Quant; Quantitative; Random; Surf; Tilt tube; UniversalLabOrders |
2.73 |
1.0k |
|
|
|
|
|
|
|
s |
|
|
|
36 |
| 1498-5 |
Glucose^10M post 0.5 g/kg glucose IV |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Serum or Plasma --10 minutes post 0.5 g/kg glucose IV |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1498-5 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose 10M p .5 g/kg Glc IV SerPl-mCnc |
|
|
|
Y |
|
10M p .5 g/kg Glc IV; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 14980-7 |
A variant subtype Ab |
PrThr |
Ser/Plas^BPU |
Pt |
Ord |
|
|
ACTIVE |
A variant subtype Ab [Presence] in Serum or Plasma from Blood product unit |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
14980-7 |
|
|
|
|
Observation |
|
|
|
0 |
A Var Subtyp Ab SerPl BPU Ql |
|
|
|
|
|
A Var Subtyp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPl^bpu; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14981-5 |
A variant subtype Ab |
PrThr |
Ser/Plas^Donor |
Pt |
Ord |
|
|
ACTIVE |
A variant subtype Ab [Presence] in Serum or Plasma from Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
14981-5 |
|
|
|
|
Observation |
|
|
|
0 |
A Var Subtyp Ab SerPl Donr Ql |
|
|
|
|
|
A Var Subtyp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Donr; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14982-3 |
A variant subtype Ab |
PrThr |
Ser/Plas |
Pt |
Ord |
|
|
ACTIVE |
A variant subtype Ab [Presence] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
14982-3 |
|
|
|
|
Observation |
|
|
|
0 |
A Var Subtyp Ab SerPl Ql |
|
|
|
|
|
A Var Subtyp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14983-1 |
I (int) subtype |
PrThr |
RBC^BPU |
Pt |
Ord |
|
|
ACTIVE |
I (intermediate) subtype [Presence] on Red Blood Cells from Blood product unit |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
14983-1 |
|
|
|
|
Observation |
|
|
|
0 |
I (Int) Subtyp RBC BPU Ql |
|
|
|
|
|
BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14984-9 |
I (int) subtype |
PrThr |
RBC^Donor |
Pt |
Ord |
|
|
ACTIVE |
I (intermediate) subtype [Presence] on Red Blood Cells from Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
14984-9 |
|
|
|
|
Observation |
|
|
|
0 |
I (Int) Subtyp RBC Donr Ql |
|
|
|
|
|
BLOOD BANK; Donr; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14985-6 |
I (int) subtype |
PrThr |
RBC |
Pt |
Ord |
|
|
ACTIVE |
I (intermediate) subtype [Presence] on Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
14985-6 |
|
|
|
|
Observation |
|
|
|
0 |
I (Int) Subtyp RBC Ql |
|
|
|
|
|
BLOOD BANK; Erythrocytes; Hematology; Heme; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14986-4 |
little i-1 subtype |
PrThr |
RBC^BPU |
Pt |
Ord |
|
|
ACTIVE |
little i-1 subtype [Presence] on Red Blood Cells from Blood product unit |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
14986-4 |
|
|
|
|
Observation |
|
|
|
0 |
little i1 subtype RBC BPU Ql |
|
|
|
|
|
BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Erythrocytes; Hematology; Heme; i; i1; little i1; little i1 subtype; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14987-2 |
little i-1 subtype |
PrThr |
RBC^Donor |
Pt |
Ord |
|
|
ACTIVE |
little i-1 subtype [Presence] on Red Blood Cells from Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
14987-2 |
|
|
|
|
Observation |
|
|
|
0 |
little i1 subtype RBC Donr Ql |
|
|
|
|
|
BLOOD BANK; Donr; Erythrocytes; Hematology; Heme; i; i1; little i1; little i1 subtype; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14988-0 |
little i-1 subtype |
PrThr |
RBC |
Pt |
Ord |
|
|
ACTIVE |
little i-1 subtype [Presence] on Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
14988-0 |
|
|
|
|
Observation |
|
|
|
0 |
little i1 subtype RBC Ql |
|
|
|
|
|
BLOOD BANK; Erythrocytes; Hematology; Heme; i; i1; little i1; little i1 subtype; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14989-8 |
little i-2 subtype |
PrThr |
RBC^BPU |
Pt |
Ord |
|
|
ACTIVE |
little i-2 subtype [Presence] on Red Blood Cells from Blood product unit |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
14989-8 |
|
|
|
|
Observation |
|
|
|
0 |
little i2 subtype RBC BPU Ql |
|
|
|
|
|
BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Erythrocytes; Hematology; Heme; i; i2; II; little i2; little i2 subtype; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 1499-3 |
Glucose^1H post 0.5 g/kg glucose IV |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Mass/volume] in Serum or Plasma --1 hour post 0.5 g/kg glucose IV |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHAL |
|
1499-3 |
|
|
|
|
Both |
|
|
|
0 |
Glucose 1h p .5 g/kg Glc IV SerPl-mCnc |
|
|
|
Y |
|
1 hour; 1.0Hr; 1h p .5 g/kg Glc IV; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Mass concentration; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 14990-6 |
little i-2 subtype |
PrThr |
RBC^Donor |
Pt |
Ord |
|
|
ACTIVE |
little i-2 subtype [Presence] on Red Blood Cells from Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
14990-6 |
|
|
|
|
Observation |
|
|
|
0 |
little i2 subtype RBC Donr Ql |
|
|
|
|
|
BLOOD BANK; Donr; Erythrocytes; Hematology; Heme; i; i2; II; little i2; little i2 subtype; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14991-4 |
little i-2 subtype |
PrThr |
RBC |
Pt |
Ord |
|
|
ACTIVE |
little i-2 subtype [Presence] on Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
14991-4 |
|
|
|
|
Observation |
|
|
|
0 |
little i2 subtype RBC Ql |
|
|
|
|
|
BLOOD BANK; Erythrocytes; Hematology; Heme; i; i2; II; little i2; little i2 subtype; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14992-2 |
O group |
PrThr |
RBC^BPU |
Pt |
Ord |
|
|
ACTIVE |
O group [Presence] on Red Blood Cells from Blood product unit |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
14992-2 |
|
|
|
|
Observation |
|
|
|
0 |
O Group RBC BPU Ql |
|
|
|
|
|
BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Erythrocytes; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14993-0 |
O group |
PrThr |
RBC^Donor |
Pt |
Ord |
|
|
ACTIVE |
O group [Presence] on Red Blood Cells from Donor |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
14993-0 |
|
|
|
|
Observation |
|
|
|
0 |
O Group RBC Donr Ql |
|
|
|
|
|
BLOOD BANK; Donr; Erythrocytes; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14994-8 |
O group |
PrThr |
RBC |
Pt |
Ord |
|
|
ACTIVE |
O group [Presence] on Red Blood Cells |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
BLDBK |
|
14994-8 |
|
|
|
|
Both |
|
|
|
0 |
O Group RBC Ql |
|
|
|
|
|
BLOOD BANK; Erythrocytes; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Red blood cells; Red blood corpusles; Screen |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14995-5 |
Glucose^2H post 75 g glucose PO |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --2 hours post 75 g glucose PO |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
14995-5 |
|
|
|
|
Both |
|
|
|
0 |
Glucose 2h p 75 g Glc PO SerPl-sCnc |
|
|
|
Y |
|
120 min; 120 minutes; 120min; 2 hours; 2h p 75 g Glc PO; 75Gm; After; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; p 75 g Glc PO; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 14996-3 |
Glucose^pre 75 g glucose PO |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Glucose [Moles/volume] in Serum or Plasma --pre 75 g glucose PO |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHAL |
|
14996-3 |
|
|
|
|
Observation |
|
|
|
0 |
Glucose pre 75 g Glc PO SerPl-sCnc |
|
|
|
Y |
|
75Gm; Before; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; Glu; Glu tol; Gluc; Glucose tolerance; Glucoseur; GTT; Level; Pl; Plasma; Plsm; Point in time; pre 75 g Glc PO; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.34 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 14997-1 |
Thyrotropin^30M post dose TRH IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Thyrotropin [Units/volume] in Serum or Plasma --30 minutes post dose TRH IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L;mcU/mL |
|
|
|
|
|
|
CHAL |
|
14997-1 |
|
|
|
|
Observation |
|
|
|
0 |
TSH 30M p TRH IV SerPl-aCnc |
|
|
|
Y |
|
30M p TRH; 30M p TRH IV; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; p dose; p TRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH |
2.73 |
1.0k |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
| 14998-9 |
Thyrotropin^1H post dose TRH IV |
ACnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Thyrotropin [Units/volume] in Serum or Plasma --1 hour post dose TRH IV |
|
MIN |
DefinitionDescription |
|
|
mIU/L;mcU/mL |
|
|
|
|
|
|
CHAL |
|
14998-9 |
|
|
|
|
Observation |
|
|
|
0 |
TSH 1h p TRH IV SerPl-aCnc |
|
|
|
Y |
|
1 hour; 1.0Hr; 1h p TRH; 1h p TRH IV; 60 min; 60 minutes; 60M; 60min; After; Arbitrary concentration; CHEMISTRY.CHALLENGE TESTING; Endocrine; Endocrinology; p dose; p TRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Thyroid stimulating hormone; Thyrotropic hormone; TSH |
2.73 |
1.0k |
|
|
|
|
|
|
|
m[IU]/L |
|
|
|
0 |
